Skip to content

comparing the efficacy of methotrexate and laparoscopic salpingostomy in treating patients with ectopic pregnancy and their role in fallopian tubes patency

comparing the efficacy of methotrexate and laparoscopic salpingostomy in treating patients with ectopic pregnancy and their role in fallopian tubes patency

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201212121556N49
Enrollment
40
Registered
2012-12-23
Start date
2012-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ectopic pregnancy. Ectopic pregnancy

Interventions

Intervention 1: MTX (two doses). Intervention 2: laparoscopic salpingostomy.
Treatment - Drugs
Treatment - Surgery
MTX (two doses)
laparoscopic salpingostomy

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: 1- hemodynamic stability 2- ectopic mass size below 4 cm 3- patients' commitment for complete treatment and follow up 4- absence of MTX treatment contraindication Exclusion criteria: 1- breast feeding 2- immune deficiency 3- abnormalities in hematologic system including anemia, locopenia, thrombocytopenia 4- known hypersensivity reaction to MTX 5- acute respiratory disease 6- acute peptic ulcer 7- alcoholism 8- clinical malfunction of liver and kidney 9- evidence of acute intraabdominal bleeding 10- evidence of cardiac function in the embryo 11- clinical sign and symptom of ectopic pregnancy, or B-hCG level below 5000 IU/L (with mild sign and symptoms)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
B-hCG level. Timepoint: at the end of study. Method of measurement: blood sampling.

Secondary

MeasureTime frame
Fallopian tubes patency. Timepoint: eight weeks after the time that B-hCG test became negative. Method of measurement: histerosalpingography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ladan Kashani

Tehran University of Medical Sciences

Kashani_ladan@tums.ac.ir+98 21 7788 3195

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026